comparemela.com

Latest Breaking News On - American society of ophthalmic administrators - Page 1 : comparemela.com

Ocuphire Announces Peer-Reviewed Publication in BMC

Allegro Ophthalmics Announces Positive Results of Vehicle-controlled Ex-U S Phase 2 Trial of ALG-1007 for the Treatment of Dry Eye Disease

Press release content from Business Wire. The AP news staff was not involved in its creation. Allegro Ophthalmics Announces Positive Results of Vehicle-controlled Ex-U.S. Phase 2 Trial of ALG-1007 for the Treatment of Dry Eye Disease July 24, 2021 GMT SAN JUAN CAPISTRANO, Calif. (BUSINESS WIRE) Jul 24, 2021 Allegro Ophthalmics, LLC, a privately held biopharmaceutical company focused on the development of novel oxidative stress stabilizers for the treatment of ocular diseases, today announced that all primary and secondary endpoints of an ex-U.S. vehicle-controlled study of ALG-1007 topical eye drop in patients with dry eye disease (DED) were met. The results were presented by Eric D. Donnenfeld, M.D., at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators (ASCRS ASOA) Annual Meeting in Las Vegas. 1

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.